Multicenter, randomized, double-blind, placebo-controlled, single-ascending dose study of the oral γ-secretase inhibitor BMS-708163 (Avagacestat): tolerability profile, pharmacokinetic parameters, and pharmacodynamic markers
口服 γ-分泌酶抑制剂 BMS-708163(Avagacestat)的多中心、随机、双盲、安慰剂对照、单次递增剂量研究:耐受性概况、药代动力学参数和药效学标志物
期刊:Clinical Therapeutics
影响因子:3.2
doi:10.1016/j.clinthera.2012.01.022
Gary Tong, Jun-Sheng Wang, Oleksandr Sverdlov, Shu-Pang Huang, Randy Slemmon, Robert Croop, Lorna Castaneda, Huidong Gu, Oi Wong, Hewei Li, Robert M Berman, Christina Smith, Charles F Albright, Randy C Dockens